Related Experiment Video
Updated: Jan 16, 2026

10:55
Comprehensive Assessment of Germline Chemical Toxicity Using the Nematode Caenorhabditis elegans
Published on: February 22, 2015
8.5K
A Scoping Review on Male-Mediated Developmental Toxicity
Lidia Caporossi1, Paola Castellano1, Enrico Paci1
1Department of Occupational and Environmental Medicine, Epidemiology and Hygiene, INAIL, National Institute for Insurance against Accidents at Work, 00078 Monte Porzio Catone, Italy.
Toxics
|September 27, 2025
Summary
Paternal exposure to environmental toxicants can harm offspring development. Research shows the male germ line is vulnerable, impacting child health through various biochemical pathways.
Area of Science:
- Toxicology
- Reproductive Science
- Developmental Biology
Background:
- Developmental toxicity encompasses adverse effects from parental exposure during pregnancy or preconception.
- Maternal exposure is well-studied, but paternal exposure's role in developmental toxicity is often underestimated.
Purpose of the Study:
- To investigate and emphasize the impact of male-mediated developmental toxicity.
- To consolidate evidence on adverse offspring outcomes linked to paternal toxicant exposure.
Main Methods:
- Systematic literature review using PubMed, Scopus, and Google Scholar.
- Focused on studies examining developmental toxicity in offspring following paternal preconception exposure.
Main Results:
- Paternal exposure to diverse chemicals (pharmaceuticals, substances of abuse, environmental toxins) adversely affects offspring health.
- Biochemical mechanisms mediate the adverse effects of paternal exposure on offspring development.
- Specific toxicants include tobacco, alcohol, opioids, cannabinoids, phthalates, organic solvents, and pesticides.
Conclusions:
- Substantial evidence confirms male-mediated developmental toxicity, highlighting male germ line vulnerability.
- Proposed biochemical pathways explain the observed toxicity.
- Human evidence, while complex, indicates potential developmental risks from paternal exposure to substances of abuse and occupational chemicals.
More Related Videos
Related Concept Videos
Teratogenicity
4.0K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.0K
Mutagenicity and Carcinogenicity
1.9K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.9K
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K

